The results further revealed positive correlations between serum ApoJ/TC and ApoJ/LDL in patients with CHC (r = 0.417, 0.433; p = 0.011, 0.008, Fig. 6a, b) and in patients with NAFLD with steatosis grade ≧ 2 (r = 0.649, 0.701; p = 0.031, 0.016, Fig. 6c, d). Here, CLU is linked to metabolic dysfunction-associated steatotic liver disease.